CD3G and neoplasm: Except for miR-515 and miR-136, which were only cited once (oral squamous cell [44] and lung cancer [51] respectively), which showed an increasing number of miRNAs in tumor tissues), no other literature is available regarding the number of other miRNAs predicted for targeting CD3G in tumor tissues or blood sera of cancer patients (Table 5).